AdaptHealth Corp. Quarterly Depreciation in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
AdaptHealth Corp. quarterly/annual Depreciation history and growth rate from Q1 2019 to Q3 2024.
  • AdaptHealth Corp. Depreciation for the quarter ending September 30, 2024 was $85.2M, a 5.65% decline year-over-year.
  • AdaptHealth Corp. Depreciation for the twelve months ending September 30, 2024 was $345M, a 3.04% decline year-over-year.
  • AdaptHealth Corp. annual Depreciation for 2023 was $350M, a 12.5% increase from 2022.
  • AdaptHealth Corp. annual Depreciation for 2022 was $311M, a 47.1% increase from 2021.
  • AdaptHealth Corp. annual Depreciation for 2021 was $212M, a 177% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $345M $85.2M -$5.1M -5.65% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $350M $85.6M -$3.7M -4.14% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $354M $87.3M +$3.5M +4.18% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $350M $86.8M -$5.5M -5.96% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $356M $90.3M +$7.9M +9.59% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $348M $89.3M +$19.9M +28.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $328M $83.8M +$16.7M +24.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $311M $92.3M +$27.3M +42% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $284M $82.4M +$22.7M +38% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $261M $69.4M +$19.5M +39.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $242M $67.1M +$30.2M +81.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $212M $65M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $59.7M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $49.9M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $36.9M +$20.2M +120% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $16.7M +$1.77M +11.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 $15M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.